These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32917434)

  • 1. Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection.
    Porta-Etessam J; Yus M; González García N; Valcarcel A; Barrado-Cuchillo J; Pérez-Somarriba J
    Neurologia (Engl Ed); 2020; 35(9):701-703. PubMed ID: 32917434
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection.
    Barrachina-Esteve O; Palau Domínguez A; Hidalgo-Torrico I; Viguera Martínez ML
    Neurologia (Engl Ed); 2020; 35(9):710-712. PubMed ID: 32891435
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection.
    Álvarez Bravo G; Ramió I Torrentà L
    Neurologia (Engl Ed); 2020; 35(9):699-700. PubMed ID: 32912742
    [No Abstract]   [Full Text] [Related]  

  • 4. Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report.
    Ordoñez-Boschetti L; Torres-Romero CM; Ortiz de Leo MJ
    Neurologia (Engl Ed); 2020; 35(9):696-698. PubMed ID: 32896464
    [No Abstract]   [Full Text] [Related]  

  • 5. Myopathy associated with severe SARS-CoV-2 infection.
    Abenza Abildúa MJ; Ramírez Prieto MT; Moreno Zabaleta R; Algarra Lucas C; Pérez López C
    Neurologia (Engl Ed); 2020; 35(9):706-708. PubMed ID: 32893072
    [No Abstract]   [Full Text] [Related]  

  • 6. Convulsive status epilepticus as a possible symptom of COVID-19 in a patient with intellectual disability and autistic spectrum disorder.
    Peña-Salazar C; López Cuiña M; Chavarría V; Robles Olmo B
    Neurologia (Engl Ed); 2020; 35(9):703-705. PubMed ID: 32893073
    [No Abstract]   [Full Text] [Related]  

  • 7. Orbitofrontal involvement in a neuroCOVID-19 patient.
    Le Guennec L; Devianne J; Jalin L; Cao A; Galanaud D; Navarro V; Boutolleau D; Rohaut B; Weiss N; Demeret S
    Epilepsia; 2020 Aug; 61(8):e90-e94. PubMed ID: 32589794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
    Coskun Benlidayi I; Kurtaran B; Tirasci E; Guzel R
    Rheumatol Int; 2020 Oct; 40(10):1707-1716. PubMed ID: 32591970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
    Million M; Roussel Y; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
    [No Abstract]   [Full Text] [Related]  

  • 11. Encephalopathy and COVID-19: a case report.
    Lazraq M; Benhamza S; Saadaoui S; Hayar S; Louardi M; Moujahid H; Bensaid A; Miloudi Y; Harrar NE
    Pan Afr Med J; 2021; 38():139. PubMed ID: 33912309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

  • 13. Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.
    Gomes CP; Fernandes DE; Casimiro F; da Mata GF; Passos MT; Varela P; Mastroianni-Kirsztajn G; Pesquero JB
    Front Cell Infect Microbiol; 2020; 10():589505. PubMed ID: 33364201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata in a patient with SARS-Cov-2 infection.
    Sgubbi P; Savoia F; Calderoni O; Longo R; Stinchi C; Tabanelli M
    Dermatol Ther; 2020 Nov; 33(6):e14295. PubMed ID: 32909635
    [No Abstract]   [Full Text] [Related]  

  • 15. Report on Electroencephalographic Findings in Critically Ill Patients with COVID-19.
    Vespignani H; Colas D; Lavin BS; Soufflet C; Maillard L; Pourcher V; Paccoud O; Medjebar S; Frouin PY
    Ann Neurol; 2020 Sep; 88(3):626-630. PubMed ID: 32533727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.
    Ann Intern Med; 2021 Mar; 174(3):I16. PubMed ID: 33284685
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease in Visual Acuity in a 77-Year-old Woman with Age-Related Macular Degeneration after a SARS-CoV-2 Infection Treated with Hydroxychloroquine.
    Bajka A; Toro M; Kniestedt C; Zweifel S
    Klin Monbl Augenheilkd; 2022 Apr; 239(4):527-530. PubMed ID: 35472798
    [No Abstract]   [Full Text] [Related]  

  • 18. Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.
    Ciorba A; Skarżyński PH; Pelucchi S; Hatzopoulos S
    J Glob Antimicrob Resist; 2020 Dec; 23():263-264. PubMed ID: 33075521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection].
    Troldborg A; Bartels LE; Deleuran B
    Ugeskr Laeger; 2020 May; 182(20):. PubMed ID: 32400380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
    Patel PA; Lapp SA; Grubbs G; Edara VV; Rostad CA; Stokes CL; Pauly MG; Anderson EJ; Piantadosi A; Suthar MS; Khurana S; Sabnis HS
    Br J Haematol; 2021 Aug; 194(3):549-553. PubMed ID: 34096051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.